Pre-planned feasibility and safety analyses of docetaxel/S-1 combination in a phase III study comparing docetaxel/S-1 with S-1 alone as postoperative adjuvant chemotherapy for stage III gastric cancer (JACCRO GC-07).

被引：1
|
作者：
Kakeji, Yoshihiro
Kodera, Yasuhiro
Yoshida, Kazuhiro
Kochi, Mitsugu
Takahashi, Masazumi
Kii, Takayuki
Ishiguro, Atsushi
Ishigure, Kiyoshi
Takagane, Akinori
Matsui, Takanori
Kaji, Masahide
Ichikawa, Wataru
Sano, Takeshi
Takeuchi, Masahiro
Fujii, Masashi
Nakajima, Toshifusa
机构：
[1] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4648601, Japan
[3] Gifu Univ, Sch Med, Gifu 500, Japan
[4] Nihon Univ, Sch Med, Tokyo, Japan
[5] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan
[6] Osaka Med Coll Hosp, Ctr Canc Chemotherapy, Osaka, Japan
[7] Teine Keijinkai Hosp, Sapporo, Hokkaido, Japan
[8] Konan Kosei Hosp, Konan, Japan
[9] Hakodate Goryokaku Hosp, Hakodate, Hokkaido, Japan
[10] Aichi Canc Ctr Hosp, Okazaki, Aichi, Japan
[11] Toyama Prefectural Cent Hosp, Toyama, Japan
[12] Showa Univ, Tokyo, Japan
[13] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[14] Kitasato Univ, Tokyo, Japan
[15] Japan Clin Canc Res Org, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15000
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A randomized phase III study of neoadjuvant chemotherapy with docetaxel(D), oxaliplatin(O), and S-1(S) (DOS) followed by surgery and adjuvant S-1 vs. surgery and adjuvant S-1 for resectable advanced gastric cancer (PRODIGY).
    Kang, Yoon-Koo
    Yook, Jeong Hwan
    Ryu, Min-Hee
    Lee, Jong Seok
    Park, Youngkyu
    Chung, Ik-Joo
    Jung, Minkyu
    Kim, Young Woo
    Kim, Mi-Jung
    Oh, Sang Cheul
    Kim, Samyong
    Kim, Jong Gwang
    Song, Hong-Suk
    Ryu, Seung Wan
    Roh, Sang Young
    Kook, Myeong-Cherl
    Shim, Kyoo Jung
    Lee, Jeehyun
    Kim, Gyunji
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).
    Yamada, Yasuhide
    Boku, Narikazu
    Mizusawa, Junki
    Iwasa, Satoru
    Kadowaki, Shigenori
    Nakayama, Norisuke
    Azuma, Mizutomo
    Sakamoto, Takeshi
    Shitara, Kohei
    Okuno, Tatsuya
    Chin, Keisho
    Nozaki, Akira
    Nakamura, Masaki
    Hara, Hiroki
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Yoshikawa, Takaki
    Sano, Takeshi
    Sasako, Mitsuru
    Terashima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] A multicenter phase II study of sequential paclitaxel and S-1 (TXL/S-1) as postoperative adjuvant chemotherapy for gastric cancer (GC).
    Nagata, N
    Tsuburaya, A
    Kimura, M
    Emi, Y
    Hirabayashi, N
    Kobayashi, M
    Itoh, H
    Sakamoto, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 324S - 324S
  • [24] Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial
    Kim, Y. H.
    Koizumi, W.
    Lee, K. H.
    Kishimoto, T.
    Chung, H. C.
    Hara, T.
    Cho, J. Y.
    Nakajima, T.
    Kim, H.
    Fujii, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer
    Eiji Oki
    Yasunori Emi
    Tetsuya Kusumoto
    Yoshihisa Sakaguchi
    Manabu Yamamoto
    Noriaki Sadanaga
    Mototsugu Shimokawa
    Takeharu Yamanaka
    Hiroshi Saeki
    Masaru Morita
    Ikuo Takahashi
    Naoki Hirabayashi
    Kenji Sakai
    Hiroyuki Orita
    Shinichi Aishima
    Yoshihiro Kakeji
    Kazuya Yamaguchi
    Kazuhiro Yoshida
    Hideo Baba
    Yoshihiko Maehara
    Annals of Surgical Oncology, 2014, 21 : 2340 - 2346
  • [26] Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer
    Oki, Eiji
    Emi, Yasunori
    Kusumoto, Tetsuya
    Sakaguchi, Yoshihisa
    Yamamoto, Manabu
    Sadanaga, Noriaki
    Shimokawa, Mototsugu
    Yamanaka, Takeharu
    Saeki, Hiroshi
    Morita, Masaru
    Takahashi, Ikuo
    Hirabayashi, Naoki
    Sakai, Kenji
    Orita, Hiroyuki
    Aishima, Shinichi
    Kakeji, Yoshihiro
    Yamaguchi, Kazuya
    Yoshida, Kazuhiro
    Baba, Hideo
    Maehara, Yoshihiko
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (07) : 2340 - 2346
  • [27] Phase I study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer
    Kunisaki, Chikara
    Takahashi, Masazumi
    Nagahori, Yutaka
    Makino, Hirochika
    Takagawa, Ryo
    Sato, Tsutomu
    Oshima, Takashi
    Fujii, Shoichi
    Kosaka, Takashi
    Ono, Hidetaka A.
    Akiyama, Hirotoshi
    Shimada, Hiroshi
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2473 - 2478
  • [28] Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
    Wang, Fei-Yu
    Huang, Xiang-Ming
    Cao, Yu-Qing
    Cao, Jie
    Song, Meng
    Fang, Zhi-Jun
    Huang, Xin-En
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
  • [29] Combination chemotherapy of S-1, docetaxel and CDDP for the treatment of advanced gastric cancer
    Niitsu, Yoshiro
    Takayama, Tetsuji
    Sato, Yasushi
    Sagawa, Tamotsu
    Abe, Seichiro
    Kato, Junji
    ANNALS OF ONCOLOGY, 2006, 17 : 313 - 314
  • [30] Factors and timing of decreased adherence to S-1 in postoperative docetaxel + S-1 therapy for gastric cancer.
    Kawakami, Kazuyoshi
    Kimura, Yuka
    Nakamura, Masashi
    Yokokawa, Takashi
    Kobayashi, Kazuo
    Aoyama, Takeshi
    Suzuki, Wataru
    Hatori, Masahiro
    Shimizu, Hisanori
    Hiraide, Makoto
    Suzuki, Kenichi
    Takahari, Daisuke
    Yamaguchi, Kensei
    Yamaguchi, Masakazu
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 403 - 403
12345